Osteosarcoma

HC Beird, SS Bielack, AM Flanagan, J Gill… - Nature reviews Disease …, 2022 - nature.com
Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma
incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in …

Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century

MJ Ehrhardt, KR Krull, N Bhakta, Q Liu… - Nature Reviews …, 2023 - nature.com
The contributions of cooperative groups to performing large-cohort clinical trials and long-
term survivorship studies have facilitated advances in treatment, supportive care and …

Cisplatin in liver cancer therapy

S Hamaya, K Oura, A Morishita, T Masaki - International Journal of …, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common primary liver tumor and is often
diagnosed at an unresectable advanced stage. Systemic chemotherapy as well as …

[HTML][HTML] European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer

RJ van Kalsbeek, HJH van der Pal, LCM Kremer… - European journal of …, 2021 - Elsevier
Background Long-term follow-up (LTFU) care for childhood, adolescent, and young adult
(CAYA) cancer survivors is essential to preserve health and quality of life (QoL). Evidence …

Cisplatin ototoxicity in children: a practical grading system

PR Brock, SC Bellman, EC Yeomans… - Medical and …, 1991 - Wiley Online Library
A long‐term follow‐up study was carried out to assess ototoxicity in children who had been
treated for a malignant tumour with “standard dose” cisplatin (60–; 100 mg/m2 per course) …

Recommendations for the surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors: a report from the International Late …

JG Marchak, S Christen, RL Mulder, K Baust… - The Lancet …, 2022 - thelancet.com
Survivors of childhood, adolescent, and young adult (diagnosed when< 25 years of age)
cancer are at risk of mental health problems. The aim of this clinical practice guideline is to …

Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review

AJ L'Hotta, SB Randolph, B Reader… - CA: A Cancer …, 2023 - Wiley Online Library
Increased attention to the rehabilitation needs of children with cancer is vital to enhance
health, quality‐of‐life, and productivity outcomes. Among adults with cancer, rehabilitation …

Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study

DJ Moke, C Luo, J Millstein, KR Knight… - The Lancet Child & …, 2021 - thelancet.com
Background Cisplatin is used to treat a wide range of childhood cancers and cisplatin-
induced hearing loss (CIHL) is a common and debilitating toxicity. We aimed to address …

Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline

DR Freyer, PR Brock, KW Chang, LL Dupuis… - The lancet child & …, 2020 - thelancet.com
Despite ototoxicity being a prevalent consequence of cisplatin chemotherapy, little guidance
exists on interventions to prevent this permanent and progressive adverse event. To develop …

The battlefield of chemotherapy in pediatric cancers

L Bo, Y Wang, Y Li, JND Wurpel, Z Huang, ZS Chen - Cancers, 2023 - mdpi.com
Simple Summary The survival rate for pediatric cancers has improved significantly over the
last decades. Conventional chemotherapies play a vital role in pediatric cancer treatment …